SCHEMBL25844742

SCHEMBL25844742

COc1ccc2c3c(c4c(c2c1)OC(c1ccc(N2CCOCC2)cc1)(c1ccc2c(c1)C(C)(C)c1ccccc1-2)C=C4)C(C)(C)c1ccccc1-3

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.35
PDK2 Q15119 1/20 0.33
ADAM17 P78536 1/20 0.32
MAPT P10636 4/20 0.32
KDM4E B2RXH2 4/20 0.32
ALDH1A1 P00352 4/20 0.32
HTT P42858 3/20 0.32
MAPK1 P28482 3/20 0.32
PRKDC P78527 3/20 0.31
TSHR P16473 3/20 0.31
HSD17B10 Q99714 3/20 0.31
KMT2A Q03164 3/20 0.31
POLB P06746 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PIK3C3 Q8NEB9 2/20 0.31
TP53 P04637 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
MEN1 O00255 2/20 0.30
LMNA P02545 2/20 0.30
CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25844743 0.96 ATM (0.33) ATMPDK2ADAM17MAPTKDM4E
SCHEMBL25717701 0.95 ATM (0.36) ATMADAM17MAPTKDM4EALDH1A1
SCHEMBL25606729 0.95 ATM (0.35) ATMADAM17MAPTKDM4EALDH1A1
SCHEMBL25606728 0.94 ATM (0.35) ATMADAM17MAPTKDM4EALDH1A1
SCHEMBL25600316 0.93 ATM (0.33) ATMPDK2ADAM17PIK3C3
SCHEMBL25844746 0.93 ATM (0.33) ATMADAM17MAPTKDM4EALDH1A1
SCHEMBL25718378 0.92 ALDH1A1 (0.36) ATMADAM17MAPTKDM4EALDH1A1
SCHEMBL25606847 0.92 RAB9A (0.34) ATMPDK2ADAM17MAPTKDM4E
SCHEMBL25606848 0.92 RAB9A (0.34) ATMPDK2ADAM17MAPTKDM4E
SCHEMBL30708906 0.92 RAB9A (0.35) ATMADAM17MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230227717-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES HOYA LENS THAILAND LTD. (TH) 2023-07-20 US disclosed
US-20230227717-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES HOYA LENS THAILAND LTD. (TH) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES NR2E3, CRY1, RPS10 ATM 1606/4885PDK2 2722/4885ADAM17 4791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.